Rapid Dose Therapeutics Corp. Stock
Equities
DOSE
CA75339A1012
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.255 CAD | +2.00% | +24.39% | +54.55% |
03-25 | Rapid Dose Therapeutics Corp. announced that it expects to receive CAD 6 million in funding | CI |
02-08 | Rapid Dose Therapeutics Corp. Appoints Angela O'Leary to the Board of Directors | CI |
Sales 2022 | 1.75 2.39 | Sales 2023 | 0.72 0.98 | Capitalization | 9.32M 12.74M |
---|---|---|---|---|---|
Net income 2022 | -8M -10.94M | Net income 2023 | -3M -4.1M | EV / Sales 2022 | 15,898,275 x |
Net Debt 2022 | 1.4M 1.91M | Net Debt 2023 | 2.1M 2.86M | EV / Sales 2023 | 15,894,851 x |
P/E ratio 2022 |
-3.01
x | P/E ratio 2023 |
-2.44
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 90.12% |
1 day | +2.00% | ||
1 week | +24.39% | ||
Current month | +41.67% | ||
1 month | +50.00% | ||
3 months | +59.38% | ||
6 months | +13.33% | ||
Current year | +54.55% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Upsdell
CEO | Chief Executive Officer | - | 17-05-02 |
Doug Hyland
DFI | Director of Finance/CFO | - | 20-02-27 |
Corporate Officer/Principal | - | 19-01-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Sheldon
LAW | General Counsel | 77 | 19-12-05 |
John McKimm
BRD | Director/Board Member | - | 23-04-13 |
Director/Board Member | - | 20-08-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.255 | +2.00% | 81,000 |
24-04-25 | 0.25 | 0.00% | 107,970 |
24-04-24 | 0.25 | +13.64% | 36,000 |
24-04-23 | 0.22 | +4.76% | 222,585 |
24-04-22 | 0.21 | +2.44% | 5,000 |
Delayed Quote Canadian Securities Exchange, April 26, 2024 at 10:38 am
More quotes1st Jan change | Capi. | |
---|---|---|
+54.55% | 22.5M | |
-10.84% | 187M | |
-59.36% | 82M |
- Stock Market
- Equities
- DOSE Stock